Poster Session B - Monday Morning
Category: Liver
John Bruckbauer
Thomas Jefferson University
Philadelphia, PA
| Total Patients (%) | Mean BMI (95% CI) | p-value | |
At Transplant | At 1 year after Transplant | |||
Overall | 90 (100) | 31.01 (29.90-32.13) | 30.88 (29.59-32.17) | 0.16 |
Indication for Transplant | ||||
NASH/NAFLD | 27 (30.7) | 33.08 (31.12-35.03) | 32.30 (31.55-33.06) | 0.21 |
Alcohol | 11 (12.5) | 26.19 (23.22-29.16) | 25.96 (24.12-27.80) | 0.45 |
HCV | 9 (10.2) | 30.81 (27.35-34.27) | 31.23 (28.83-33.62) | 0.36 |
HBV | 2 (2.3) | 37.2 (49.12-25.28) | 34.40 (57.76-11.04) | 0.13 |
PSC | 1 (1.1) | 25.8 (n/a) | 26.3 (n/a) | n/a |
HCC | 3 (3.4) | 29.00 (25.88-32.12) | 28.53 (24.20-32.86) | 0.30 |
Cirrhosis NOS / Cryptogenic | 13 (14.8) | 28.57 (25.65-31.49) | 29.54 (27.89-31.19) | 0.21 |
HCV+HCC | 18 (20.5) | 32.09 (29.65-34.53) | 31.63 (30.47-32.79) | 0.19 |
NASH+HCC | 2 (2.3) | 31.40 (19.48-43.32) | 33.72 (10.36-57.08) | 0.13 |
Alcohol+HCC | 2 (2.3) | 30.00 (20.45-39.55) | 28.51 (9.80-47.23) | 0.37 |